Showing 651-653 of 653 results for "continuous glucose monitoring"
Breakthrough T1D and Youth Delegates Urge Senators to Continue Support of Type One Diabetes Research
Delegates, Matthew Nemeti and Jocelyn Goldberg proudly represented the Breakthrough T1D Maryland Chapter at the 2019 Children’s Congress! In a packed U.S. Senate hearing room, Breakthrough T1D Children’s Congress Delegates, medical leaders and celebrities today shared the personal, critical need for ongoing federal funding of research for type 1 diabetes (T1D). The two senators leading […]
Breakthrough T1D San Diego’s Chris Stiehl on Living with T1D for 54 Years
The recent Google Hangout on Diabetes sparked what I thought was a great conversation about the status of research on diabetes today. The topics dealt primarily with type 1 diabetes, but there were implications for type 2 as well. We packed a lot into the one-hour Hangout, but there were so many things we didn’t […]
FDA Approves Tzield™—A Watershed Moment for the T1D Community
Today, the U.S. Food and Drug Administration (FDA) weighed the evidence for teplizumab to delay type 1 diabetes (T1D) in at-risk individuals, and the T1D community got a big win: Approved, under the brand name Tzield™! Tzield (teplizumab-mzwv) is the first disease-modifying therapy for individuals at-risk for developing T1D. (At-risk means that they exhibited 2+ T1D-related autoantibodies—antibodies against one’s […]
